Trial · NCT01829464
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in HbA1c at Week 24 | Placebo | Baseline (n= 26, 31, 27) | 8.39 | Standard Deviation 0.766 | Percentage of glycosylated haemoglobin |
| Change From Baseline in HbA1c at Week 24 | Fasiglifam 25 mg QD | Baseline (n= 26, 31, 27) | 8.46 | Standard Deviation 0.932 | Percentage of glycosylated haemoglobin |
| Change From Baseline in HbA1c at Week 24 | Fasiglifam 50 mg QD | Baseline (n= 26, 31, 27) | 8.52 | Standard Deviation 0.956 | Percentage of glycosylated haemoglobin |
| Change From Baseline in HbA1c at Week 24 | Placebo | Change at Week 24 (n= 2, 4, 2) | 0.25 | Standard Deviation 0.495 | Percentage of glycosylated haemoglobin |
| Change From Baseline in HbA1c at Week 24 | Fasiglifam 25 mg QD | Change at Week 24 (n= 2, 4, 2) | -0.80 | Standard Deviation 0.883 | Percentage of glycosylated haemoglobin |
| Change From Baseline in HbA1c at Week 24 | Fasiglifam 50 mg QD | Change at Week 24 (n= 2, 4, 2) | -1.85 | Standard Deviation 0.495 | Percentage of glycosylated haemoglobin |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24 | Placebo | Baseline (n= 29, 31, 28) | 193.76 | Standard Deviation 50.090 | milligram per deciliter (mg/dL) |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24 | Fasiglifam 25 mg QD | Baseline (n= 29, 31, 28) | 184.52 | Standard Deviation 45.126 | milligram per deciliter (mg/dL) |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24 | Fasiglifam 50 mg QD | Baseline (n= 29, 31, 28) | 185.96 | Standard Deviation 53.767 | milligram per deciliter (mg/dL) |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24 | Placebo | Change at Week 24 (n= 2, 2, 2) | 30.50 | Standard Deviation 55.861 | milligram per deciliter (mg/dL) |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24 | Fasiglifam 25 mg QD | Change at Week 24 (n= 2, 2, 2) | -31.50 | Standard Deviation 16.263 | milligram per deciliter (mg/dL) |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24 | Fasiglifam 50 mg QD | Change at Week 24 (n= 2, 2, 2) | -85.50 | Standard Deviation 23.335 | milligram per deciliter (mg/dL) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01829464/results